Semi-Annual Statement Of Cash Flows

Carna Biosciences, Inc. - Filing #7571400

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-687,837,000 JPY
-1,582,110,000 JPY
Interest paid
-5,128,000 JPY
-4,097,000 JPY
Net cash provided by (used in) operating activities
-708,390,000 JPY
-1,536,612,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-125,831,000 JPY
-41,522,000 JPY
Other, net
305,000 JPY
JPY
Net cash provided by (used in) investing activities
-125,696,000 JPY
-41,677,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
JPY
300,000,000 JPY
Redemption of bonds
-28,028,000 JPY
-28,028,000 JPY
Repayments of long-term borrowings
-211,497,000 JPY
-161,897,000 JPY
Net cash provided by (used in) financing activities
367,006,000 JPY
1,064,987,000 JPY
Other, net
JPY
-3,080,000 JPY
Effect of exchange rate change on cash and cash equivalents
28,293,000 JPY
31,994,000 JPY
Net increase (decrease) in cash and cash equivalents
-438,786,000 JPY
-481,307,000 JPY
Cash and cash equivalents
3,379,048,000 JPY
3,817,834,000 JPY
4,299,142,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.